With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...

An announcement from Moleculin Biotech ( ($MBRX) ) is now available. On July 9, 2025, Moleculin Biotech announced that the Regulation Agency for ...

China's biotech sector is rapidly advancing due to heavy R&D investment and a push for technological self-sufficiency. See the complete analysis here.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other industries as biotechnology has delivered only subpar investor returns.

For all the attention on U.S.-China AI competition, new studies point to China's rapid rise in biotechnology, especially for drug and agricultural development.

Biotech’s Birthplace: How UCSF Sparked a Medical Renaissance – Twice The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

Without people in the room who can understand the biotech sector and its needs, we will fail to effectively navigate this increasingly important theater for U.S.-China geopolitical competition.

The Trinidad and Tobago government Friday said it intends to become the first Caribbean Community (Caricom) country to enter ...

One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.

(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release. T… ...